EYPT
Eyepoint Pharmaceuticals Inc
NASDAQ: EYPT · HEALTHCARE · BIOTECHNOLOGY
$13.20
+2.64% today
Updated 2026-04-30
Market cap
$1.08B
P/E ratio
—
P/S ratio
34.35x
EPS (TTM)
$-3.17
Dividend yield
—
52W range
$5 – $19
Volume
1.2M
Eyepoint Pharmaceuticals Inc (EYPT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |